Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and age of onset in schizophrenia: A combined analysis of independent samples

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 156, Issue 2, 2011, Pages 215-224

  Saetre, Peter ^a   Vares, Maria ^a   Werge, Thomas ^b   Andreassen, Ole A ^c,d   Arinami, Tadao ^e   Ishiguro, Hiroki ^e   Nanko, Shinichiro ^f   Tan, Ene Choo ^g,h   Han, Doug Hyun ⁱ   Roffman, Joshua L ^j   Muntjewerff, Jan Willem ^k   Jagodzinski, Pawel P ^l   Kempisty, Bartosz ^l   Hauser, Joanna ^l   Vilella, Elisabet ^m   Betcheva, Elitza ⁿ   Nakamura, Yusuke ^o   Regland, Björn ^p   Agartz, Ingrid ^a,c,q   Hall, Håkan ^a,r   Terenius, Lars ^a   Jönsson, Erik G ^a   more..

^a KAROLINSKA INSTITUTE   (Sweden)

^b Mental Health Services CPH   (Denmark)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF TSUKUBA   (Japan)

^f TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^h NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

ⁱ Chung Ang University College of Medicine   (South Korea)

^j MASSACHUSETTS GENERAL HOSPITAL   (United States)

^k RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^l POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^m IISPV   (Spain)

ⁿ MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^o UNIVERSITY OF TOKYO   (Japan)

^p UNIVERSITY OF GOTHENBURG   (Sweden)

^q DIAKONHJEMMET HOSPITAL   (Norway)

^r UPPSALA UNIVERSITY   (Sweden)

more..

Author keywords

Age of onset; Methylenetetrahydrofolate reductase gene (MTHFR); Schizophrenia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ARTICLE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; ONSET AGE; PRIORITY JOURNAL; SCHIZOPHRENIA;

AGE OF ONSET; ALLELES; CARBON CYCLE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; META-ANALYSIS AS TOPIC; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC; SCHIZOPHRENIA; YOUNG ADULT;

EID: 79551714936     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31160     Document Type: Article

References (71)

1. Allen NC, Bagade S, McQueen MB, Ioannidis JPA, Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L. 2008. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database. Nat Genet 40:827-834.
2. Arinami T, Yamada N, Yamakawa-Kobayashi K, Hamaguchi H, Toru M. 1997. Methylenetetrahydrofolate reductase variant and schizophrenia/depression. Am J Med Genet 74:526-528.
3. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
4. Betcheva ET, Mushiroda T, Takahashi A, Kubo M, Karachanak SK, Zaharieva IT, Vazharova RV, Dimova II, Milanova VK, Tolev T, Kirov G, Owen MJ, O'Donovan MC, Kamatani N, Nakamura Y, Toncheva DI. 2009. Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population. J Hum Genet 54:98-107.
5. Brown NM, Pratt VM, Buller A, Pike-Buchanan L, Redman JB, Sun W, Chen R, Crossley B, McGinniss MJ, Quan F, Strom CM. 2005. Detection of 677CT/1298AC "double variant" chromosomes: Implications for interpretation of MTHFR genotyping results. Genet Med 7:278-282.
6. Buchanan RW, Carpenter WT. 2005. Concept of schizophrenia. In: Sadock BJ, Sadock VA, editors. Kaplan & Sadock's Comprehensive Textbook of Psychiatry. Philadephia, Pa, USA; London, UK: Lippincott Williams & Wilkins. 1329.
7. Cardno AG, Holmans PA, Rees MI, Jones LA, McCarthy GM, Hamshere ML, Williams NM, Norton N, Williams HJ, Fenton I, Murphy KC, Sanders RD, Gray MY, O'Donovan MC, McGuffin P, Owen MJ. 2001. A genomewide linkage study of age at onset in schizophrenia. Am J Med Genet 105:439-445.
8. DeLisi LE. 1992. The significance of age of onset for schizophrenia. Schizophr Bull 18:209-215.
9. Domagala TB, Adamek L, Nizankowska E, Sanak M, Szczeklik A. 2002. Mutations C677T and A1298C of the 5, 10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease. Blood Coagul Fibrinolysis 13:423-431.
10. Eggers C, Bunk D. 1997. The long-term course of childhood-onset schizophrenia: A 42-year followup. Schizophr Bull 23:105-117.
11. Ellingrod VL, Miller del D, Taylor SF, Moline J, Holman T, Kerr J. 2008. Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants. Schizophr Res 98:47-54.
12. Esslinger C, Walter H, Kirsch P, Erk S, Schnell K, Arnold C, Haddad L, Mier D, Opitz von Boberfeld C, Raab K, Witt SH, Rietschel M, Cichon S, Meyer-Lindenberg A. 2009. Neural mechanisms of a genome-wide supported psychosis variant. Science 324:605.
13. Feng LG, Song ZW, Xin F, Hu J. 2009. Association of plasma homocysteine and methylenetetrahydrofolate reductase C677T gene variant with schizophrenia: A Chinese Han population-based case-control study. Psychiatry Res 168:205-208.
14. Field AP. 2001. Can meta-analysis be trusted? Psychologist 16:642-645.
15. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuve LP, Rozen R. 1995. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113.
16. Gilbody S, Lewis S, Lightfoot T. 2007. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: A HuGE review. Am J Epidemiol 165:1-13.
17. Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG, Rozen R. 1994. Human methylenetetrahydrofolate reductase: Isolation of cDNA, mapping and mutation identification. Nat Genet 7:195-200.
18. Hanson NQ, Aras O, Yang F, Tsai MY. 2001. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: Incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Clin Chem 47:661-666.
19. Hare E, Glahn DC, Dassori A, Raventos H, Nicolini H, Ontiveros A, Medina R, Mendoza R, Jerez A, Muñoz R, Almasy L, Escamilla MA. 2010. Heritability of age of onset of psychosis in schizophrenia. Am J Med Genet Part B 153B:298-302.
20. Hazra A, Kraft P, Lazarus R, Chen C, Chanock SJ, Jacques P, Selhub J, Hunter DJ. 2009. Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway. Hum Mol Genet 18:4677-4687.
21. Hoff AL, Harris D, Faustman WO, Beal M, DeVilliers D, Mone RD, Moses JA, Csernansky JG. 1996. A neuropsychological study of early onset schizophrenia. Schizophr Res 20:21-28.
22. Isotalo PA, Donnelly JG. 2000. Prevalence of methylenetetrahydrofolate reductase mutations in patients with venous thrombosis. Mol Diagn 5:59-66.
23. Isotalo PA, Wells GA, Donnelly JG. 2000. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: An examination of C677T and A1298C mutations. Am J Hum Genet 67:986-990.
24. Johnstone EC, Owens DG, Bydder GM, Colter N, Crow TJ, Frith CD. 1989. The spectrum of structural brain changes in schizophrenia: Age of onset as a predictor of cognitive and clinical impairments and their cerebral correlates. Psychol Med 19:91-103.
25. Jönsson EG, Larsson K, Vares M, Hansen T, Wang AG, Djurovic S, Rønningen KS, Andreassen OA, Agartz I, Werge T, Terenius L, Hall H. 2008. Two methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms, schizophrenia and bipolar disorder: An association study. Am J Med Genet Part B 147B:976-982.
26. Joober R, Benkelfat C, Lal S, Bloom D, Labelle A, Lalonde P, Turecki G, Rozen R, Rouleau GA. 2000. Association between the methylenetetrahydrofolate reductase 677C→T missense mutation and schizophrenia. Mol Psychiatry 5:323-326.
27. Kempisty B, Mostowska A, Gorska I, Luczak M, Czerski P, Szczepankiewicz A, Hauser J, Jagodzinski PP. 2006. Association of 677C>T polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene with bipolar disorder and schizophrenia. Neurosci Lett 400:267-271.
28. Kempisty B, Bober A, Luczak M, Czerski P, Szczepankiewicz A, Hauser J, Jagodzinski PP. 2007. Distribution of 1298A>C polymorphism of methylenetetrahydrofolate reductase gene in patients with bipolar disorder and schizophrenia. Eur Psychiatry 22:39-43.
29. Koga M, Ishiguro H, Horiuchi Y, Albalushi T, Inada T, Iwata N, Ozaki N, Ujike H, Muratake T, Someya T, Arinami T. 2007. Failure to confirm the association between the FEZ1 gene and schizophrenia in a Japanese population. Neurosci Lett 417:326-329.
30. Krajinovic M, Lamothe S, Labuda D, Lemieux-Blanchard E, Theoret Y, Moghrabi A, Sinnett D. 2004. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 103:252-257.
31. Kunugi H, Fukuda R, Hattori M, Kato T, Tatsumi M, Sakai T, Hirose T, Nanko S. 1998. C677T polymorphism in methylenetetrahydrofolate reductase gene and psychoses. Mol Psychiatry 3:435-437.
32. Lee YS, Han DH, Jeon CM, Lyoo IK, Na C, Chae SL, Cho SC. 2006. Serum homocysteine, folate level and methylenetetrahydrofolate reductase 677, 1298 gene polymorphism in Korean schizophrenic patients. Neuroreport 17:743-746.
33. Lencz T, Morgan TV, Athanasiou M, Dain B, Reed CR, Kane JM, Kucherlapati R, Malhotra AK. 2007. Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Mol Psychiatry 12:572-580.
34. Lewis SJ, Zammit S, Gunnell D, Smith GD. 2005. A meta-analysis of the MTHFR C677T polymorphism and schizophrenia risk. Am J Med Genet Part B 135B:2-4.
35. Lievers KJ, Boers GH, Verhoef P, den Heijer M, Kluijtmans LA, van der Put NM, Trijbels FJ, Blom HJ. 2001. A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk. J Mol Med 79:522-528.
36. Mavros M, Chirita V, Popescu O, Ferencz B. 2008. The genetic polymorphism of MTHFR gene in schizophrenia. Rev Med Chir Soc Med Nat Iasi 112:76-82.
37. Muntjewerff JW, van der Put N, Eskes T, Ellenbroek B, Steegers E, Blom H, Zitman F. 2003. Homocysteine metabolism and B-vitamins in schizophrenic patients: Low plasma folate as a possible independent risk factor for schizophrenia. Psychiatry Res 121:1-9.
38. Muntjewerff JW, Hoogendoorn ML, Kahn RS, Sinke RJ, Den Heijer M, Kluijtmans LA, Blom HJ. 2005. Hyperhomocysteinemia, methylenetetrahydrofolate reductase 677TT genotype, and the risk for schizophrenia: A Dutch population based case-control study. Am J Med Genet Part B 135B:69-72.
39. Muntjewerff JW, Kahn RS, Blom HJ, den Heijer M. 2006. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: A meta-analysis. Mol Psychiatry 11:143-149.
40. Need AC, Ge D, Weale ME, Maia J, Feng S, Heinzen EL, Shianna KV, Yoon W, Kasperaviciute D, Gennarelli M, Strittmatter WJ, Bonvicini C, Rossi G, Jayathilake K, Cola PA, McEvoy JP, Keefe RS, Fisher EM, St Jean PL, Giegling I, Hartmann AM, Moller HJ, Ruppert A, Fraser G, Crombie C, Middleton LT, St Clair D, Roses AD, Muglia P, Francks C, Rujescu D, Meltzer HY, Goldstein DB. 2009. A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet 5:e1000373.
41. Peerbooms O, Rutten B, Decoster J, van Os J, Kenis G, De Hert M, van Winkel R. 2010. No association between MTHFR C677T or A1298C and age at onset of schizophrenia. Am J Med Genet Part B. 153B:1362-1363.
42. Philibert R, Gunter T, Hollenbeck N, Adams WJ, Bohle P, Packer H, Sandhu H. 2006. No association of the C677T methylenetetrahydrofolate reductase polymorphism with schizophrenia. Psychiatr Genet 16:221-223.
43. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P. 2009. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460:748-752.
44. Rajji TK, Ismail Z, Mulsant BH. 2009. Age at onset and cognition in schizophrenia: Meta-analysis. Br J Psychiatry 195:286-293.
45. Raz S, Raz N. 1990. Structural brain abnormalities in the major psychoses: A quantitative review of the evidence from computerized imaging. Psychol Bull 108:93-108.
46. Regland B, Germgård T, Gottfries CG, Grenfeldt B, Koch-Schmidt AC. 1997. Homozygous thermolabile methylenetetrahydrofolate reductase in schizophrenia-like psychosis. J Neural Transm 104:931-941.
47. Roffman JL, Weiss AP, Deckersbach T, Freudenreich O, Henderson DC, Purcell S, Wong DH, Halsted CH, Goff DC. 2007. Effects of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism on executive function in schizophrenia. Schizophr Res 92:181-188.
48. Roffman JL, Gollub RL, Calhoun VD, Wassink TH, Weiss AP, Ho BC, White T, Clark VP, Fries J, Andreasen NC, Goff DC, Manoach DS. 2008a. MTHFR 677C→T genotype disrupts prefrontal function in schizophrenia through an interaction with COMT 158Val→Met. Proc Natl Acad Sci USA 105:17573-17578.
49. Roffman JL, Weiss AP, Deckersbach T, Freudenreich O, Henderson DC, Wong DH, Halsted CH, Goff DC. 2008b. Interactive effects of COMT Val108/158Met and MTHFR C677T on executive function in schizophrenia. Am J Med Genet Part B 147B:990-995.
50. Roffman JL, Weiss AP, Purcell S, Caffalette CA, Freudenreich O, Henderson DC, Bottiglieri T, Wong DH, Halsted CH, Goff DC. 2008c. Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia. Biol Psychiatry 63:42-48.
51. Rosenthal R. 1991. Meta-analytic procedures for social research. Newbury Park, CA: Sage.
52. Rothenbacher D, Fischer HG, Hoffmeister A, Hoffmann MM, Marz W, Bode G, Rosenthal J, Koenig W, Brenner H. 2002. Homocysteine and methylenetetrahydrofolate reductase genotype: Association with risk of coronary heart disease and relation to inflammatory, hemostatic, and lipid parameters. Atherosclerosis 162:193-200.
53. Sazci A, Ergul E, Guzelhan Y, Kaya G, Kara I. 2003. Methylenetetrahydrofolate reductase gene polymorphisms in patients with schizophrenia. Brain Res Mol Brain Res 117:104-107.
54. Sazci A, Ergul E, Kucukali I, Kara I, Kaya G. 2005. Association of the C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene with schizophrenia: Association is significant in men but not in women. Prog Neuropsychopharmacol Biol Psychiatry 29:1113-1123.
55. Shen H, Spitz MR, Wang LE, Hong WK, Wei Q. 2001. Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: A case-control study. Cancer Epidemiol Biomarkers Prev 10:397-401.
56. Shi J, Gershon ES, Liu C. 2008. Genetic associations with schizophrenia: Meta-analyses of 12 candidate genes. Schizophr Res 104:96-107.
57. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe'er I, Dudbridge F, Holmans PA, Whittemore AS, Mowry BJ, Olincy A, Amin F, Cloninger CR, Silverman JM, Buccola NG, Byerley WF, Black DW, Crowe RR, Oksenberg JR, Mirel DB, Kendler KS, Freedman R, Gejman PV. 2009. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460:753-757.
58. Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA, Morgan G. 1999. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 96:12810-12815.
59. Song C, Xing D, Tan W, Wei Q, Lin D. 2001. Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 61:3272-3275.
60. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, Werge T, Pietilainen OP, Mors O, Mortensen PB, Sigurdsson E, Gustafsson O, Nyegaard M, Tuulio-Henriksson A, Ingason A, Hansen T, Suvisaari J, Lönnqvist J, Paunio T, Borglum AD, Hartmann A, Fink-Jensen A, Nordentoft M, Hougaard D, Norgaard-Pedersen B, Bottcher Y, Olesen J, Breuer R, Möller HJ, Giegling I, Rasmussen HB, Timm S, Mattheisen M, Bitter I, Rethelyi JM, Magnusdottir BB, Sigmundsson T, Olason P, Masson G, Gulcher JR, Haraldsson M, Fossdal R, Thorgeirsson TE, Thorsteinsdottir U, Ruggeri M, Tosato S, Franke B, Strengman E, Kiemeney LA, Genetic Risk and Outcome in Psychosis (GROUP), Melle I, Djurovic S, Abramova L, Kaleda V, Sanjuan J, de Frutos R, Bramon E, Vassos E, Fraser G, Ettinger U, Picchioni M, Walker N, Toulopoulou T, Need AC, Ge D, Lim Yoon J, Shianna KV, Freimer NB, Cantor RM, Murray R, Kong A, Golimbet V, Carracedo A, Arango C, Costas J, Jönsson EG, Terenius L, Agartz I, Petursson H, Nöthen MM, Rietschel M, Matthews PM, Muglia P, Peltonen L, St Clair D, Goldstein DB, Stefansson K, Collier DA, Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I, 2009. Common variants conferring risk of schizophrenia. Nature 460:744-747.
61. Sullivan PF, Lin D, Tzeng JY, van den Oord E, Perkins D, Stroup TS, Wagner M, Lee S, Wright FA, Zou F, Liu W, Downing AM, Lieberman J, Close SL. 2008. Genomewide association for schizophrenia in the CATIE study: Results of stage 1. Mol Psychiatry 13:570-584.
62. Tan EC, Chong SA, Lim LC, Chan AO, Teo YY, Tan CH, Mahendran R. 2004. Genetic analysis of the thermolabile methylenetetrahydrofolate reductase variant in schizophrenia and mood disorders. Psychiatr Genet 14:227-231.
63. van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ. 1998. A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural-tube defects? Am J Hum Genet 62:1044-1051.
64. Vares M, Saetre P, Deng H, Cai G, Liu X, Hansen T, Rasmussen HB, Werge T, Melle I, Djurovic S, Andreassen OA, Agartz I, Hall H, Terenius L, Jönsson EG. 2010. Association between methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and age of onset in schizophrenia. Am J Med Genet Part B 153B:610-618.
65. Vilella E, Virgos C, Murphy M, Martorell L, Valero J, Simo JM, Joven J, Fernandez-Ballart J, Labad A. 2005. Further evidence that hyperhomocysteinemia and methylenetetrahydrofolate reductase C677T and A1289C polymorphisms are not risk factors for schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 29:1169-1174.
66. Virgos C, Martorell L, Simo JM, Valero J, Figuera L, Joven J, Labad A, Vilella E. 1999. Plasma homocysteine and the methylenetetrahydrofolate reductase C677T gene variant: Lack of association with schizophrenia. Neuroreport 10:2035-2038.
67. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. 1998. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64:169-172.
68. Xiao Y, Shan K, Li Y, Zhao Y, Qi X, Xie Y, Wu C, Ma J, Liu H, Xu Y, Guan Z, Ren X. 2005. 5, 10-Methylenetetrahydrofolate reductase polymorphism in three nationalities of Guizhou in China. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 22:219-221.
69. Yu L, Li T, Robertson Z, Dean J, Gu N, Feng G, Yates P, Sinclair M, Crombie C, Collier DA, Walker N, He L, St Clair D. 2004. No association between polymorphisms of methylenetetrahydrofolate reductase gene and schizophrenia in both Chinese and Scottish populations. Mol Psychiatry 9:1063-1065.
70. Zetterberg H, Regland B, Palmer M, Ricksten A, Palmqvist L, Rymo L, Arvanitis DA, Spandidos DA, Blennow K. 2002. Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos. Eur J Hum Genet 10:113-118.
71. Zintzaras E. 2006. C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: A meta-analysis of genetic association studies. Psychiatr Genet 16:105-115.